Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Beyne-Rauzy

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
La Revue De Medecine Interne|June 27, 2006
[Anti PM-Scl antibodies. Study of prevalence and of meaning]C Gaudin, F Fortenfant, D Adoue, et al.
La Revue De Medecine Interne|September 15, 2004
[Anti-Ku antibodies. Study of prévalence and of clinical meaning]O Beyne-Rauzy, B Couret, F Fortenfant, et al.
Annales De Medecine Interne|July 28, 2001
[RS3PE syndrome: an acute edematous polyarthritis of the elderly with variable prognosis]O Beyne-Rauzy, V Revel, V Desfossez, et al.
La Revue De Medecine Interne|August 26, 2011
[Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]G Moulis, K Delavigne, F Huguet, et al.
La Revue De Medecine Interne|May 6, 2019
[Management of myelodysplastic syndromes in 2019: An update]T Comont, K Delavigne, P Cougoul, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 26, 2012
Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungsT Wagner, D Brechemier, E Dugert, et al.
The Journal of Nutrition, Health & Aging|May 3, 2013
Impact of an oncogeriatric consulting team on therapeutic decision-makingM E Rougé-Bugat, S Gérard, L Balardy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2010
Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndromeC Farah, C Bulai Livideanu, J Jegu, et al.
La Revue De Medecine Interne|November 1, 2019
[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update]T Comont, J Belliere, V Sibaud, et al.
QJM : Monthly Journal of the Association of Physicians|May 20, 2017
Bone marrow involvement in systemic lupus erythematosusE Chalayer, N Costedoat-Chalumeau, O Beyne-Rauzy, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
La Revue De Medecine Interne|June 27, 2006
[Anti PM-Scl antibodies. Study of prevalence and of meaning]C Gaudin, F Fortenfant, D Adoue, et al.
La Revue De Medecine Interne|September 15, 2004
[Anti-Ku antibodies. Study of prévalence and of clinical meaning]O Beyne-Rauzy, B Couret, F Fortenfant, et al.
Annales De Medecine Interne|July 28, 2001
[RS3PE syndrome: an acute edematous polyarthritis of the elderly with variable prognosis]O Beyne-Rauzy, V Revel, V Desfossez, et al.
La Revue De Medecine Interne|August 26, 2011
[Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]G Moulis, K Delavigne, F Huguet, et al.
La Revue De Medecine Interne|May 6, 2019
[Management of myelodysplastic syndromes in 2019: An update]T Comont, K Delavigne, P Cougoul, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 26, 2012
Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungsT Wagner, D Brechemier, E Dugert, et al.
The Journal of Nutrition, Health & Aging|May 3, 2013
Impact of an oncogeriatric consulting team on therapeutic decision-makingM E Rougé-Bugat, S Gérard, L Balardy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2010
Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndromeC Farah, C Bulai Livideanu, J Jegu, et al.
La Revue De Medecine Interne|November 1, 2019
[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update]T Comont, J Belliere, V Sibaud, et al.
QJM : Monthly Journal of the Association of Physicians|May 20, 2017
Bone marrow involvement in systemic lupus erythematosusE Chalayer, N Costedoat-Chalumeau, O Beyne-Rauzy, et al.
Pageof 3